Prothena Corp Public PRTA
NASDAQ PRTA
$8.78 +0.06 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) EBIT Margin (2013 - 2026)

Updated

Prothena Corp Public (PRTA) posted EBIT Margin of -2089.21% for Q2 2026, down 174.82 percentage points from -1914.39% a year earlier and down 2148.00 percentage points from the prior quarter.

Analysis

Prothena Corp Public (PRTA) EBIT Margin (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at Prothena Corp Public was -101.80%, up 2621.41 percentage points year-over-year; for FY2025, it came in at -2216.44%, down 2102.08 percentage points from FY2024.

  • Annual EBIT Margin shows a five-year change of +10999.74 percentage points (FY2020 to FY2025).
  • In prior years, Prothena Corp Public's EBIT Margin was -114.36% in FY2024 (+94.72 pp), -209.08% in FY2023 (+34.97 pp), -244.05% in FY2022 (-279.94 pp) and 35.88% in FY2021 (+13252.06 pp).
  • Quarterly EBIT Margin has run from a low of -163056.00% in Q1 2024 to a high of 78.48% in Q3 2021 over five years.
  • On a year-over-year basis, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of +8612.14 percentage points.
  • The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2025, with a gain of 160737.01 percentage points; the weakest was Q1 2024, with a drop of 160459.18 percentage points.
  • According to Business Quant data, EBIT Margin for the three prior quarters was 58.80% (Q1 2026), -115252.38% (Q4 2025) and -1666.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Prothena Corp Public 451.21 Mn -804.86 Mn - -2,089.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,089.21%
Mar 31, 2026 58.80%
Dec 31, 2025 -115,252.38%
Sep 30, 2025 -1,666.25%
Jun 30, 2025 -1,914.39%
Mar 31, 2025 -2,318.99%
Dec 31, 2024 -3,056.85%
Sep 30, 2024 -6,857.01%
Jun 30, 2024 44.22%
Mar 31, 2024 -163,056.00%
Dec 31, 2023 -24,846.52%
Sep 30, 2023 12.15%
Jun 30, 2023 -1,654.74%
Mar 31, 2023 -2,596.82%
Dec 31, 2022 -0.14%
Sep 30, 2022 -3,317.86%
Jun 30, 2022 -3,293.37%
Mar 31, 2022 -3,290.89%
Dec 31, 2021 -2,823.55%
Sep 30, 2021 78.48%
API Access

Prothena Corp Public EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PRTA&period=max&api_key=YOUR_API_KEY